{
    "Trade/Device Name(s)": [
        "BD Directigen EZ Flu A+B Test"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K063689",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001364",
        "K053126"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "December 11, 2006",
    "Summary Letter Received Date": "December 12, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral antigen",
        "Influenza B viral antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal washes/aspirates",
        "Nasopharyngeal swabs",
        "Throat swabs"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BD Directigen EZ Flu A+B Test, a rapid chromatographic immunoassay for detecting influenza A and B viral antigens.",
    "Indications for Use Summary": "Rapid qualitative detection and differentiation of influenza A and B viral antigens in nasopharyngeal and throat specimens from symptomatic patients as an aid in diagnosis, with negative results to be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}